CD4 and sarcoidosis: showed that spontaneous clinical resolution of sarcoidosis corresponds to a reduced percentage of PD-1+ CD4+ T cells, whereas clinical progression to an increase of PD-1+CD4+ T cells suggesting that the blockade of the PD-1 pathway may contribute to the restoration of CD4+ T-Cell Proliferative Capacity in Sarcoidosis patients (32).